This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Why Active Funds May Underperform Benchmarks discusses persistent headwinds, costs, and timing issues that hinder outperformance.
26,804 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
A fintech stock surged in recent years, then faced a pullback during down weeks. This article outlines a disciplined ...
Morgan Stanley’s MSBT, the bank’s first spot Bitcoin ETF, has surged to $233 million in AUM in its first month, under...
iQIYI faces a brutal 2026, but a new strategy focused on IP monetization and international growth could unlock sizabl...
Beyond Meat faces headwinds, but a protein drinks turnaround catalyst could change the game. This article breaks down...
A high-profile crypto exposure is more than a headline. This deep dive unpacks what trump media moves over Bitcoin be...
Salesforce signals a sharp hiring pivot, keeping engineers flat while expanding the sales force. The move highlights ...
A rare ‘super’ niño looking could intensify weather extremes this year, impacting crops, energy costs, and budgets. H...
Berkshire Hathaway has signaled interest in acquiring Taylor Morrison, shaking up the homebuilding landscape. The dea...
A steep rally has many investors wondering if Intel is a steal or a trap. This guide breaks down the 168% swing in 20...
Waabi’s Raquel Urtasun argues that Gen Z’s curiosity and adaptability give them a competitive edge as AI reshapes tru...
The U.K. moves to bar under-16s from major platforms, setting up a widening policy shift that could reshape families’...